[THE BEHAVIOR OF THE BLOOD LEVEL OF 4-BUTYL-2-(P-HYDROXYPHENYL)-1-PHENYL-3,5-PYRAZOLIDINEDIONE FOLLOWING RECTAL APPLICATION].
D035843:Biomedical Research; D001774:Blood Chemical Analysis; D006801:Humans; D008660:Metabolism; D010113:Oxyphenbutazone; D010570:Pessaries; D011720:Pyrazoles; D013488:Suppositories
D011720:Pyrazoles; D013488:Suppositories; C031280:pyrazole; D010113:Oxyphenbutazone
BLOOD CHEMICAL ANALYSIS; CLINICAL RESEARCH; METABOLISM; OXYPHENBUTAZONE; SUPPOSITORIES
DAS VERHALTEN DES BLUTSPIEGELS VON 1-PHENYL-2-(P-HYDROXYPHENYL)-3,5-DIOXO-4-N-BUTYL-PYRAZOLIDIN-MONOHYDRAT BEI RECTALER APPLIKATION.